Study Highlights Surgery Benefits of P/D over EPP for Mesothelioma
This study focused on 30-day mortality and postoperative complications. It included a meta-analysis of 39 previous studies from 1990 to 2017, along with the New York Statewide Planning and Research Cooperative System database from 1995 to 2012. Study results included: 30 Day Mortality: EPP 5 percent; P/D 2 percent Postoperative Complications: EPP 46 percent; P/D 24 percent Postoperative Arrhythmias: EPP 20 percent; P/D 5 percent. Although there is no cure for pleural mesothelioma, aggressive surgery — with either the P/D or EPP — has been proven to extend survival times. According to a recent study pub...
Source: Asbestos and Mesothelioma News - October 19, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

CT radiomics improves management of bile duct cancer
Researchers from China have developed a radiomics model that can determine...Read more on AuntMinnie.comRelated Reading: Radiomics helps distinguish lung cancer nodules on CT AIUM: Can deep learning classify liver fibrosis on US? AI, radiomics help distinguish lung nodules on CT scans MRI, radiomics help diagnose, discern ADHD subtypes AAPM: Radiomics helps fine-tune radiation therapy dose (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 19, 2018 Category: Radiology Source Type: news

New research shows benefits of exercise for first time in advanced lung cancer
(European Society for Medical Oncology) Most people with lung cancer are unaware of the benefits of regular exercise, yet new data show it can significantly reduce fatigue and improve well being. Results of two studies to be presented at the ESMO 2018 Congress in Munich underline the value of exercise, including in patients with advanced or metastatic lung cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 19, 2018 Category: Cancer & Oncology Source Type: news

Plasma-Based Genotyping Aids Targeted Tx of Metastatic NSCLC
THURSDAY, Oct. 18, 2018 -- Integration of plasma next-generation sequencing (NGS) into the routine management of metastatic non-small cell lung cancer (NSCLC) results in an increase in the detection of therapeutically targetable mutations, according... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 18, 2018 Category: Pharmaceuticals Source Type: news

A Patient With EGFR-Mutated Lung Cancer Progressing on Erlotinib: Evaluating for a T790M Mutation With Limited Tissue
Due to the high rate ofEGFR T790M mutations seen in NSCLC patients, the thoracic tumor board recommends genomic testing for this alteration; read our case of a 69-year-old woman with metastatic disease. (Source: CancerNetwork)
Source: CancerNetwork - October 17, 2018 Category: Cancer & Oncology Authors: Emily Wynja, MSIV, Jenna Hove, BSN, Steven F. Powell, MD Source Type: news

What Role Will Avelumab Play in Lung Cancer?
Avelumab did not improve overall survival compared with docetaxel in patients with PD-L1 –positive non–small-cell lung cancer. (Source: CancerNetwork)
Source: CancerNetwork - October 17, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Lung Cancer Deaths 28 & #37; Lower in California Than Rest of U.S.
WEDNESDAY, Oct. 17, 2018 -- Annual lung cancer mortality was 28 percent lower in California than in the rest of the United States in 2013, according to a study published online Oct. 10 in Cancer Prevention Research. John P. Pierce, Ph.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 17, 2018 Category: Pharmaceuticals Source Type: news

New method uses just a drop of blood to monitor lung cancer treatment
(Osaka University) Osaka University researchers have devised a simple method to measure the amount of cancer medication nivolumab that is bound to immune T-cells. The method requires just a drop of blood and can also measure the level of proliferation of those T-cells. The researchers show that these tests provide much more useful information for making treatment decisions than blood levels of the medication alone. Using these methods should also help reduce adverse reactions to therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 17, 2018 Category: Cancer & Oncology Source Type: news

In NSCLC, Longer Survival With Brigatinib Than Crizotinib
MONDAY, Oct. 15, 2018 -- Among patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) who have not previously received an ALK inhibitor, progression-free survival is significantly longer in those who receive... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 15, 2018 Category: Pharmaceuticals Source Type: news

For Early-State Lung Cancer Detection, GRAIL ’s Experimental Clinical Laboratory Blood Screening Test Shows Promise
Silicon Valley startup is using gene sequencing to identify in the bloodstream free-floating genetic material shed by tumors There has been plenty of excitement about the new diagnostic technologies designed to identify circulating tumor cells in blood samples. Now, a well-funded Silicon Valley startup has developed a blood test that it says holds promise for […] (Source: Dark Daily)
Source: Dark Daily - October 15, 2018 Category: Laboratory Medicine Authors: Jude Tags: Instruments & Equipment Laboratory Instruments & Laboratory Equipment Laboratory Management and Operations Laboratory News Laboratory Operations Laboratory Pathology Laboratory Testing Management & Operations Amazon American Cancer Socie Source Type: news

Auris Health touts robotically-assisted bronchoscopy study results
Auris Health’s Monarch bronchoscopy platform reached lung nodules and biopsied tissue with “high accuracy” in a recent study, according to the company. Eight investigators performed robotic-assisted bronchoscopy procedures using the Monarch platform on a cadaveric model designed to mimic a real-life bronchoscopy procedure. Sixty-seven simulated tumor targets one to three centimeters in size were prepared in eight human cadaveric lungs. The tissue acquired during the bronchoscopy was evaluated and correctly identified as the implanted target in 97% of cases, the study noted. Auris presented the results of ...
Source: Mass Device - October 15, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Featured Oncology Robotics aurishealth johnsonandjohnson Source Type: news

Philadelphia biotech firm teams up with CHOP & Penn to battle lung cancer
The partners are collaborating to advance a new approach to cancer immunotherapy that uses next-generation RNA silencing technology. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 12, 2018 Category: Pharmaceuticals Authors: John George Source Type: news

Bristol-Myers' Opdivo fails to meet lung cancer study goal
Bristol-Myers Squibb Co said on Friday that its blockbuster cancer drug Opdivo failed to meet the main goal in a late-stage trial on patients with a type of lung cancer, whose condition had relapsed after chemotherapy. (Source: Reuters: Health)
Source: Reuters: Health - October 12, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

ASTRO releases new prostate radiation therapy guideline
The American Society for Radiation Oncology (ASTRO) has released a new guideline...Read more on AuntMinnie.comRelated Reading: ASTRO elects new board president-elect Radiation oncologists prepare to meet with Congress ASTRO urges CMS to shorten MIPS reporting period ASTRO updates guideline for lung cancer radiation therapy ASTRO releases new breast radiation therapy guideline (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 12, 2018 Category: Radiology Source Type: news

ALK Testing Rates Increasing in NSCLC Patients ALK Testing Rates Increasing in NSCLC Patients
Testing for mutations in the ALK gene in patients with non-small-cell lung cancer (NSCLC) who are candidates for targeted therapy nearly doubled from 2011 to 2016, according to a new study in U.S. community practices.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - October 12, 2018 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Calif. boasts sharpest dip in lung cancer risk in U.S.
Lung cancer mortality in the state of California is 28% lower than the U.S....Read more on AuntMinnie.comRelated Reading: Report predicts plunge in U.S. lung cancer mortality CT lung screening reduces cancer mortality in men by 26% Global lung cancer death rates for women to increase Lung cancer more common in white women than men Cancer mortality continues to drop in U.S. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 11, 2018 Category: Radiology Source Type: news

Paragon Genomics Introduces CleanPlex(R) UMI Panel for Ultrafast, Precise Analysis of Lung Cancer Hotspot Mutations at ASHG 2018
First Product in Family of New CleanPlex® UMI NGS Panels that Deliver Highly Accurate Results in Detecting Low-Frequency Variants and Mutations for Liquid Biopsy and Other Applications ASHG Poster Shows CleanPlex Unique Molecular Identifier (UMI) Te... Diagnostics, Oncology, Product Launch Paragon Genomics, CleanPlex, Lung Panel, Lung Cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 11, 2018 Category: Pharmaceuticals Source Type: news

3D printing boosts efficiency of rib fracture repair
Researchers from Taiwan have created 3D-printed models of rib structures based...Read more on AuntMinnie.comRelated Reading: Virtual reality, 3D printing resolve obscure lung cancer 3D-printed device aids knee replacement surgery 3D-printed hips may improve complex fracture diagnosis 3D-printed breast phantoms help refine mammography Study: 3D-printed mandibles may reduce OR time (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 11, 2018 Category: Radiology Source Type: news

Study: Tobacco laws cited for 28% lower lung cancer rate in Calif.
Lung cancer deaths are 28 percent lower in California compared with rest of the nation with strong tobacco control in Golden State cited as the primary reason. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 10, 2018 Category: Consumer Health News Source Type: news

bioAffinity Licenses CyPath(R) Lung to Precision Pathology Services
SAN ANTONIO, Oct. 10, 2018 -- (Healthcare Sales & Marketing Network) -- bioAffinity Technologies, a privately held biotech company, today announced a licensing agreement with Precision Pathology Services for the continued development and commercial sale of... Diagnostics, Oncology, Licensing bioAffinity Technologies, Precision Pathology Services, CyPath Lung, lung cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 10, 2018 Category: Pharmaceuticals Source Type: news

Burden of Lung Cancer to Decrease Over Next 50 Years Burden of Lung Cancer to Decrease Over Next 50 Years
Thanks to tobacco control efforts implemented in the 1960s, the burden of lung cancer in the US will decrease, with deaths reduced by 79% over the next 50 years.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 10, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Lung cancer deaths are 28 percent lower in California
(University of California - San Diego) Early adoption of tobacco control efforts in California lead to fewer people ever smoking, reduced the amount used by those who do smoke and helped smokers quit at a younger age -- when their risk of developing lung cancer is lowest. As a result, lung cancer deaths are 28 percent lower in California compared to the rest of the country and the gap is widening each year by almost a percentage point. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 10, 2018 Category: International Medicine & Public Health Source Type: news

Increased survival in patients with metastatic NSCLC receiving treatment in academic centers
(International Association for the Study of Lung Cancer) Patients with metastatic NSCLC receiving treatment at academic centers (ACs) have an increased 2-year survival compared to patients treated at community-based centers (CCs). An overall histology-dependent survival was also noted in patients with adenocarcinoma verses squamous cell carcinoma and varied by treatment facility. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 10, 2018 Category: Cancer & Oncology Source Type: news

Lung cancer symptoms: A cough that won’t go away could be a sign of the deadly disease
LUNG CANCER symptoms usually don ’t appear in the early stages of the disease, but will often develop as the cancer progresses. A persistent cough that won’t go away is one sign. (Source: Daily Express - Health)
Source: Daily Express - Health - October 9, 2018 Category: Consumer Health News Source Type: news

Anti-psychotic drug could treat aggressive breast cancer
(University of Bradford) A commonly-used anti-psychotic drug could also be effective against triple negative breast cancer, the form of the disease that is most difficult to treat, new research has found. The study, led by the University of Bradford in the UK, also showed that the drug, Pimozide, has the potential to treat the most common type of lung cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 9, 2018 Category: Cancer & Oncology Source Type: news

Report predicts plunge in U.S. lung cancer mortality
In a new paper, researchers from the U.S. National Cancer Institute and other...Read more on AuntMinnie.comRelated Reading: CT lung screening reduces cancer mortality in men by 26% Global lung cancer death rates for women to increase More CT screening may be needed for high-risk smokers Female lung cancer death rate rises in U.S. regions Cancer mortality continues to drop in U.S. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 8, 2018 Category: Radiology Source Type: news

UCLA is awarded $5 million to develop tools to detect lung cancer earlier
Researchers from the UCLA School of Dentistry and the David Geffen School of Medicine at UCLA have been awarded $5 million over five years from the National Cancer Institute to develop liquid biopsy tools for testing individuals who could have lung cancer — the leading cause of cancer death in both U.S. men and women. The award, one of only six given in the nation, will support further development of the tools to improve methods for early detection of lung cancer.Today ’s standard of care in diagnosing lung cancer involves a low-dose computed tomography scan of the lungs, evaluating whether there are what are c...
Source: UCLA Newsroom: Health Sciences - October 8, 2018 Category: Universities & Medical Training Source Type: news

Lung cancer warning - why you should never ignore these bumps on the skin
LUNG cancer symptoms include a cough that doesn ’t go away, unexplained weight loss, or having a persistent croaky voice. But, you could also be at risk of lung tumour signs if you have these lumps on bumps on your skin. (Source: Daily Express - Health)
Source: Daily Express - Health - October 8, 2018 Category: Consumer Health News Source Type: news

CT lung cancer screening foiled by low adherence
More than 20% of U.S. military veterans who had a negative baseline CT lung...Read more on AuntMinnie.comRelated Reading: New decision aids may revamp CT lung cancer screening ASCO: CT lung cancer screening rates continue to stagnate Risk-based CT lung screening could be more efficient Cancer deaths continue to fall, but CT lung screening lags Smokers not picking up the CT lung screening habit (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 8, 2018 Category: Radiology Source Type: news

Novel technology enables detection of early-stage lung cancer when surgical cure still is possible
(Elsevier) To improve outcomes for patients with non-small-cell lung carcinoma researchers are developing a blood test to detect lung cancer earlier in the disease. A report in The Journal of Molecular Diagnostics describes a new technology, electric field-induced release and measurement (EFIRM) that is both highly sensitive and specific in detecting two epidermal growth factor receptor (EGFR) mutations associated with lung cancer in the blood of NSCLC patients with early-stage disease. This platform is relatively inexpensive and capable of high-throughput testing. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 8, 2018 Category: International Medicine & Public Health Source Type: news

UCLA is awarded $5 million to develop tools to detect lung cancer earlier
(University of California - Los Angeles) Researchers from the UCLA School of Dentistry and the David Geffen School of Medicine at UCLA have been awarded $5 million over five years from the National Cancer Institute to develop liquid biopsy tools for testing individuals who could have lung cancer -- the leading cause of cancer death in both US men and women. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 8, 2018 Category: Cancer & Oncology Source Type: news

Medical News Today: Nasal delivery of grape compound shows promising results in lung cancer
Administering the natural red wine anticancer compound resveratrol through the nose could protect against lung cancer, a new mouse study finds. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 5, 2018 Category: Consumer Health News Tags: Lung Cancer Source Type: news

Geographic Availability of Low-Dose Computed Tomography for Lung Cancer Screening in the United States, 2017
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - October 5, 2018 Category: International Medicine & Public Health Tags: Public Health Source Type: news

Climate Change Could Destroy This Peruvian Farmer ’s Home. Now He’s Suing a European Energy Company for Damages
Climbing a snowcapped mountain in the predawn light, Saúl Luciano Lliuya says he could sense something changing. All his life, pristine glaciers have nestled between the peaks surrounding his hometown in the Cordillera Blanca region of the Peruvian Andes, providing water, work and beauty. “Now you can see it,” he says. “They’re disappearing.” The region’s glaciers are receding rapidly; as temperatures rise, thanks to greenhouse gases trapping heat in the earth’s atmosphere, ice accumulated over thousands of years has melted away in a single generation. Between 30% and 50% of...
Source: TIME: Science - October 5, 2018 Category: Science Authors: Ciara Nugent / Hamburg Tags: Uncategorized Germany Source Type: news

Nanopore technology with DNA computing easily detects microRNA patterns of lung cancer
(Tokyo University of Agriculture and Technology) Researchers at Tokyo University of Agriculture and Technology (TUAT) have developed a simple technique that allows detection of two independent microRNAs as an early diagnosis marker of Small Cell Lung Cancer (SCLC) , which is very aggressive. In this technique, they combined nanopore and DNA computing technologies as rapid and label-free detection. This method, therefore, could help to identify SCLC in the early stage. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 5, 2018 Category: Cancer & Oncology Source Type: news

Three Digital Core Biopsies Sufficient to Determine PD-L1 Expression in NSCLC
Four or more biopsies proffer little additional benefit, found a study presented at the IASLC 19th World Conference on Lung Cancer. (Source: CancerNetwork)
Source: CancerNetwork - October 4, 2018 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news

How Pathology Changed the Lung Care Landscape
In recent years, advances in the molecular analysis of tumors and pathologic investigation have improved understanding of an ambit of lung cancer types. (Source: CancerNetwork)
Source: CancerNetwork - October 4, 2018 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news

Should Dyspnea in Lung Cancer Be Medicated?
Two presentations at the IASLC WCLC 2018 discussed the evidence on treating breathlessness with pharmacologic vs nonpharmacologic therapy. (Source: CancerNetwork)
Source: CancerNetwork - October 4, 2018 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news

Pembrolizumab Alone or With Chemotherapy for PD-L1 –Positive NSCLC?
Pembrolizumab plus chemotherapy failed to improve survival compared with pembrolizumab alone in patients with non –small-cell lung cancer. (Source: CancerNetwork)
Source: CancerNetwork - October 4, 2018 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news

Lung Cancer Screening Rates Fall Short in VA
(MedPage Today) -- Adherence was 77% among those with negative baseline screens (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - October 4, 2018 Category: American Health Source Type: news

How the 2018 WCLC Data Change Lung Cancer Practice How the 2018 WCLC Data Change Lung Cancer Practice
The 19th World Conference on Lung Cancer (WCLC), held September 23-26 in Toronto, featured a remarkable presidential session that included multiple practice-changing results.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 4, 2018 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Potent compound found in red wine kills lung-cancer cells and even PROTECTS against tumours
University of Geneva researchers found when the compound resveratrol is given to mice who have been exposed to a cancer-causing chemical, they are less likely to develop the disease. (Source: the Mail online | Health)
Source: the Mail online | Health - October 4, 2018 Category: Consumer Health News Source Type: news

Survival Reduced in Lung Cancer Patients Who Refuse Surgery Survival Reduced in Lung Cancer Patients Who Refuse Surgery
Lung cancer patients who refuse surgery face greatly compromised odds of overall survival compared to those who accept surgical resection.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 4, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

How Scientists Are Treating Breast Cancer Using the Immune System
As a pharmacist, Kathy James considers herself well educated about the importance of getting regular cancer screenings. Even though the 55-year-old had no history of cancer in her family, she never skipped her regular mammograms, and she gave herself regular breast exams. So she was dumbfounded when, during one of those self-exams in May 2017, she felt a marble-size lump in her left breast. A visit to the doctor confirmed it. “The radiologist came in with his hands in his pockets and looked down and said, ‘It doesn’t look good,'” James says. After a biopsy, James and her husband learned she had meta...
Source: TIME: Health - October 4, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized breast cancer news Frontiers of Medicine Source Type: news

How Scientists Are Treating Breast Cancer Using the Immune System
As a pharmacist, Kathy James considers herself well educated about the importance of getting regular cancer screenings. Even though the 55-year-old had no history of cancer in her family, she never skipped her regular mammograms, and she gave herself regular breast exams. So she was dumbfounded when, during one of those self-exams in May 2017, she felt a marble-size lump in her left breast. A visit to the doctor confirmed it. “The radiologist came in with his hands in his pockets and looked down and said, ‘It doesn’t look good,'” James says. After a biopsy, James and her husband learned she had meta...
Source: TIME: Science - October 4, 2018 Category: Science Authors: Alice Park Tags: Uncategorized breast cancer news Frontiers of Medicine Source Type: news

New decision aids may revamp CT lung cancer screening
Are current decision aids used to guide CT lung cancer screening biased against...Read more on AuntMinnie.comRelated Reading: CT lung screening reduces cancer mortality in men by 26% Access to CT lung screening varies by population density Are patients adequately informed about CT lung screening? 4 reasons why people seek CT lung cancer screening Patient outreach may boost uptake for CT lung screening (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 4, 2018 Category: Radiology Source Type: news

Lung Cancer Screening Lung Cancer Screening
Advances in technology have made low-dose computerized tomography a cost-effective screening strategy for lung cancer.American Journal of Public Health (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 4, 2018 Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news

Post-treatment surveillance frequency not related to improved lung cancer patient survival
(American College of Surgeons) Study findings sourced by the National Cancer Database published in Annals of Surgery also do not show that more frequent surveillance improved survival following lung cancer recurrence. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 4, 2018 Category: International Medicine & Public Health Source Type: news

Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage
The use of potent therapies inhibiting critical oncogenic pathways active in epithelial cancers has led to multiple resistance mechanisms, including the development of highly aggressive, small cell neuroendocrine carcinoma (SCNC). SCNC patients have a dismal prognosis due in part to a limited understanding of the molecular mechanisms driving this malignancy and the lack of effective treatments. Here, we demonstrate that a common set of defined oncogenic drivers reproducibly reprograms normal human prostate and lung epithelial cells to small cell prostate cancer (SCPC) and small cell lung cancer (SCLC), respectively. We ide...
Source: ScienceNOW - October 4, 2018 Category: Science Authors: Park, J. W., Lee, J. K., Sheu, K. M., Wang, L., Balanis, N. G., Nguyen, K., Smith, B. A., Cheng, C., Tsai, B. L., Cheng, D., Huang, J., Kurdistani, S. K., Graeber, T. G., Witte, O. N. Tags: Medicine, Diseases reports Source Type: news

' Transformational' Results in Squamous Cell Lung Cancer'Transformational' Results in Squamous Cell Lung Cancer
An immuno-chemotherapy combination again moves the bar forward in a difficult-to-treat subset of squamous cell lung cancer patients.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 2, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news